DWA
PRVL

Dorsey Wright & Associates’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Dorsey Wright & Associates’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-653
Closed -$10K – 391
2020
Q2 		$10K Buy
+653
New +$10K ﹤0.01% 270